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Mice injected with either of two monoclonal antibodies specific for the 0 polysaccharide of Brucella abortus
prior to challenge infection had viable counts in spleens and livers significantly below those in control groups
1 and 4 weeks later. Two monoclonal antibodies specific for the porin of B. abortus failed to confer protection.
The current understanding of Brucella abortus as an
intracellular pathogen and of protective immunity to
brucellosis is based largely on studies of mice (4, 7, 14, 18).
There is good evidence that passively transferred antibodies
confer a measure of immunity to B. abortus infection in mice
(3, 15, 17, 19, 23), yet the specificity of protective antibodies
has not been rigorously established. In this study, we tested
four monoclonal antibodies (MAbs) specific for the B.
abortus 0 polysaccharide or porin for passive protection of
mice to B. abortus infection.
Hybridomas producing MAbs against B. abortus antigens
were prepared from splenocytes of BALB/c mice immunized
with irradiated cells of B. abortus smooth strain 2308 (24) as
described previously (11). Supernatants from microtiter
wells containing hybridoma growth were analyzed for anti-
brucella antibody activity by a solid-phase enzyme-linked
immunosorbent assay (ELISA) with alkali-treated lipopoly-
saccharide (LPS) (16) or porin (24) of B. abortus 2308 as the
antigen. Selected hydridomas were recloned three times by
limiting dilution and grown to extinction in serum-free me-
dium (HB101; Hana Biologics, San Diego, Calif.). Serum-
free medium supernatants were concentrated to 10.0 mg of
immunoglobulin per ml and isotyped with anti-mouse
isotype-specific ELISA procedures (Table 1). In nitrocellu-
lose electroblots of sodium dodecyl sulfate-polyacrylamide
gels of a whole-cell extract of strain 2308 MAbs 144 and 145
reacted with a single band corresponding to the porin (24),
whereas MAbs 34 and 47 reacted with the typical multiple
bands of LPS (22), and MAb 135 failed to react with any
antigen (Table 1). Inhibition tests were performed with
purified 0 antigen (25), which had been established to be a
perosamine homopolymer by nuclear magnetic resonance
analysis in confirmation of a previous report (6), and purified
porin electroeluted from sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis gels, which migrated as a single
band in sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis in accordance with published reports (24). Compet-
itive inhibition assays of the nitrocellulose blots demon-
strated that 25 ,ug of purified porin inhibited a 1:200 dilution
of MAbs 144 and 145, whereas 10 ,ug of purified 0 antigen
inhibited a 1:200 dilution of MAbs 34 and 47. In addition,
competitive inhibition ELISAs (25) were performed with
soluble strain 2308 antigen (12) attached to the solid phase.
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The purified 0 antigen inhibited MAb 34 86%, MAb 47 88%,
MAb 144 4%, and MAb 145 6%. Purified porin inhibited
MAb 34 9%, MAb 45 6%, MAb 144 89%, and MAb 145 81%.
Female 10-week-old Balb/cByJ mice (Jackson Labora-
tory, Bar Harbor, Maine) were used throughout the study.
After an 18-h fast, groups of five mice were injected intra-
peritoneally (i.p.) with 100 ,ug of MAb (in 0.1 to 0.5 ml of
serum-free tissue culture supernatant) or 0.5 ml of sterile
phosphate-buffered saline (PBS). Four hours later, mice
were inoculated i.p. with 5 x 104 CFU of virulent B. abortus
2308 in 0.1 ml of PBS. To prepare the challenge suspension,
a 48-h culture on Schaedler blood agar (24) was suspended in
sterile PBS and adjusted turbidimetrically to 5 x 105
CFU/ml. The exact dose was calculated retrospectively by
viable counts. At 1 or 4 weeks postinfection (p.i.), mice were
killed by cervical dislocation, and spleens and livers were
removed aseptically. The organs were homogenized in 10 ml
of PBS with a Sorvall Omni-Mixer (DuPont Co., Wilming-
ton, Del.). Serial 10-fold dilutions were plated on Schaedler
blood agar, and colonies were counted after 3 days of
incubation at 37°C in air containing 5% CO2.
In a preliminary experiment, the effect of MAbs were
tested on the course of infection after 1 week in the spleen
(Table 2). Statistical significance was assessed with a
Bonferroni multiple-comparison t-test procedure at an
experimentwise error rate of 5% (21). Analysis of variance
revealed no significant differences in counts between the
groups receiving PBS and control antibody 135 or those
receiving 0 antibodies 34 and 47, so the data from those
pairs were pooled for further analyses. 0 antibodies reduced
viable counts by more than 2 logs (P < 0.0005). Counts
obtained from groups treated with porin antibodies differed
from one another (P < 0.05), although neither differed
significantly from the pooled control. Plommet and Plommet
(19) tested the protective effects in mice of polyvalent
antisera directed against the crude LPS or sodium dodecyl
sulfate-insoluble extract (PG). Both types of antisera, admin-
istered intravenously simultaneously with the challenge
inoculum, caused a shift of infection from spleen to liver
detectable up to 7 days p.i., so that bacterial numbers in
livers of passively immunized mice in fact exceeded those in
control groups (19). By p.i. day 21, PG antisera had pro-
duced a progressive decrease in spleen counts, whereas
spleen counts in mice treated with LPS antisera differed little
from those at 7 days (19). To examine these questions in our
system, were injected mice i.p. with 100 ,ug of 0-specific
MAbs and enumerated B. abortus in spleens and livers at 1
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TABLE 1. Properties of MAbs
Titera
Clone Specificity for B. Isotype Agglutinationb Complement ELISAd Keabortus Agglutination
~~~~~~~~~~fixationc LS
135 Nonef IgGl(K) <5 <5 <5
144 Porin IgM(K) <5 <5 800 6.0 x 109
145 Porin IgM(K) <5 <5 1600 6.2 x 109
34 0 polysaccharide IgG2a(K) 100 256 >1,600,000 7.6 x 1010
47 0 polysaccharide IgG3(X) <5 16 25,600 8.9 x 109
a Based on an initial concentration of 10.0 mg/ml.
b Standard plate agglutination test (2).
c Standard tube cold complement fixation test with a whole-cell antigen (1).
d Microtiter assay (5) using porin with MAbs 144 and 145, 0 polysaccharide with MAbs 34 and 47, and both antigens with MAb 135.
e Relative estimated association constant expressed as liters per mole per molecule of IgM or IgG based on Scatchard plot analysis.
f Produced no reaction against any B. abortus antigen tested.
TABLE 2. Effect of passive immunization of mice with MAbs on
spleen colonization by B. abortus 1 week after infection
Antibodya Loglo brucella in spleen ± SD
None.6.44 ± 0.14
135 ± 0.20
144.6.78 ± 0.33
145 5 94 ± 0.37
34.4.00 ± 0.41
47 3 75 ± 0.72
a One hundred p.g injected i.p. 4 h before i.p. infection with 5 x 104 CFU of
B. abortus.
b Injected with 0.5 ml of PBS.
TABLE 3. Effect of passive immunization of mice with MAbs on
spleen and liver colonization 1 and 4 weeks after infection
Log1o brucella ± SD
Antibodya Spleen Liver
1 week 4 weeks 1 week 4 weeks
Noneb 6.41 ± 0.25 6.47 ± 0.28 4.90 ± 0.24 4.79 ± 0.47
135 6.56 ± 0.41 6.42 ± 0.53 4.71 ± 0.48 5.12 ± 0.39
34 3.34 ± 0.54 4.65 ± 1.18 3.29 ± 0.67 2.78 ± 0.93
47 2.50 ± 0.53 5.69 ± 0.61 2.76 ± 0.38 3.63 ± 1.03
a One hundred p.g injected i.p. 4 h before i.p. infection with 5 x 104 CFU of
B. abortus.
b Injected with 0.5 ml of PBS.
and 4 weeks p.i. (Table 3). Again, no significant differences
in counts occurred at either period in livers or spleens
between the two groups injected with 0-specific MAbs and
the two control groups, so data were pooled. Immunization
with 0-specific MAbs significantly reduced the numbers of
brucella in spleen (P < 0.0005 at 1 week and P < 0.005 at 4
weeks p.i.) and liver (P < 0.0005 at 1 and 4 weeks p.i.). The
differences in spleen counts between immunized and control
groups diminished between 1 and 4 weeks (P < 0.0005),
whereas corresponding differences in liver counts were not
significantly altered. This is in general accord with Plommet
and Plommet, who observed an early but not a late protec-
tive effect due to LPS antibodies (19). Our failure to observe
early deflection of infection into the liver (19) might be
explained in part by differences in route and timing in the
administration of antibody and challenge inoculum. More-
over, in our experiment, counts in livers of control groups
differed little between the two periods and were 1 to 2 logs
below those in the spleen (Table 3). In contrast, Plommet
and Plommet (19) reported counts in livers of control animals
at 1 week p.i. that were much higher than those in spleens,
with a marked reduction between 1 and 3 weeks. The
reasons for these differences are unclear, although a princi-
pal contributing factor may have been the difference in route
of infection.
In recent reports, protection has been conferred on mice
by MAbs specific for the LPS of Pseudomonas aeruginosa
(20), Escherichia coli O111:B4 (13), and Salmonella
typhimurium (8), although in the latter study little success
was achieved with the inherently susceptible C3H/HeJ strain
in accord with Eisenstein et al. (9). The protective efficacy of
MAbs varied and could be correlated with activity in ELISA
(8) or agglutination (20) tests. The 0-specific MAbs used in
our study differed substantially in their serological activities
and association constants (Table 1), yet their efficacies were
generally similar (Tables 2 and 3). Dose titrations may reveal
differences in the protective capacities of MAbs 34 and 47
which were not apparent in this study.
The failure of MAbs specific for porin to provide protec-
tion may have been a consequence of their inabilty to fix
complement on whole cells (Table 1). MAbs of immunoglob-
ulin M (IgM) or IgG isotype which were specific for outer
membrane proteins of P. aeruginosa provided some protec-
tion but were much less effective than those specific for LPS
(20). Protection of infant rats against Haemophilus influ-
enzae type b with an MAb specific for an outer membrane
protein has also been reported (10).
The results reported here provide the basis for a more
detailed analysis of the role played by antibodies in immu-
nity to B. abortus. Findings to date are consistent with the
hypothesis that 0 antibodies are an important component in
protective immunity and serve to complement the cell-
mediated immune response.
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